Evidence map›Paper›PMID 39853441›Full record

ArticleRheumatology international2025

Patients with antiphospholipid antibodies preferentially seek health information from physicians: a cross-sectional online patient quantitative survey.

Alexandra O Kobza, Francesca S Cardwell, Susan J Elliott, Paul S Gibson, Nancy Soliman, Leslie Skeith, Ann E Clarke, Megan R W Barber

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Patient opinion in rheumatology matters.Rheumatology international · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexandra O KobzaDivision of Rheumatology, Department of Medicine, University of Calgary, Cumming School of Medicine, Calgary, AB, Canada.
Francesca S CardwellDepartment of Geography & Environmental Management, University of Waterloo, Waterloo, ON, Canada. fcardwell@uwaterloo.ca.ORCID 0000-0002-7393-466X
Susan J ElliottDepartment of Geography & Environmental Management, University of Waterloo, Waterloo, ON, Canada.
Paul S GibsonDepartment of Obstetrics & Gynecology, University of Calgary, Cumming School of Medicine, Calgary, AB, Canada.
Nancy SolimanDepartment of Obstetrics & Gynecology, University of Calgary, Cumming School of Medicine, Calgary, AB, Canada.ORCID 0000-0001-8057-2903
Leslie SkeithDivision of Hematology & Hematological Malignancies, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.ORCID 0000-0002-5587-398X
Ann E ClarkeDivision of Rheumatology, Department of Medicine, University of Calgary, Cumming School of Medicine, Calgary, AB, Canada.ORCID 0000-0002-3112-9646
Megan R W BarberDivision of Rheumatology, Department of Medicine, University of Calgary, Cumming School of Medicine, Calgary, AB, Canada.ORCID 0000-0003-1055-1335

Funding

Arthritis Society Chair in Rheumatic Diseases Arthritis Society Chair in Rheumatic DiseasesM.S.I. Research Foundation M.S.I. Research Foundation
6 · The paper itself

Abstract

Little is known about how patients with antiphospholipid syndrome (APS) or antiphospholipid antibodies (aPL) access and trust health information. This research aimed to: describe the sources of information most frequently accessed/trusted by patients with APS/aPL; identify if individuals with APS/aPL perceived their health had been negatively impacted by various sources and document obstacles to accessing health information. Patients meeting Revised Sapporo Criteria for APS or with ≥1 positive aPL on ≥2 occasions were recruited to an online survey regarding their health information use at diagnosis and within 6 months preceding survey completion. McNemar tests were used to compare percentages accessing and trusting each source at diagnosis/currently. 69 patients completed the survey; 88.4% were female, mean age was 47.4 years (SD 15.1). The sources most frequently accessed at diagnosis and currently were rheumatologists/lupus specialists, hematologists, and family physicians, yet patients accessed family physicians (47.8% vs. 31.9%, difference -15.9%, 95% CI - 29.2%, -2.7%) and hematologists (47.8% vs. 31.9%, difference -15.9%, 95% CI -31.1%, -0.8%) less frequently from diagnosis to currently. The most trusted sources at diagnosis and currently were rheumatologists/lupus specialists (82.6% vs. 92.8%) and family physicians (66.7% vs. 68.1%). Few respondents reported negative impacts from advocacy organizations (4.4%), websites (5.8%) and social media (4.4%). 20.3% reported challenges communicating with healthcare providers. Patients with aPL/APS preferentially seek health information from and trust their physicians. However, 20.3% of patients felt communication with healthcare providers was an obstacle to accessing information. There is a need for enhanced patient-physician communication.

Indexed as

Antibodies, AntiphospholipidAntiphospholipid SyndromeHealth Knowledge, Attitudes, PracticeInformation Seeking BehaviorPhysician-Patient RelationsAdultCross-Sectional StudiesFemaleHumansInternetMaleMiddle AgedSurveys and QuestionnairesTrustAntibodies, AntiphospholipidAntibodiesAntibody syndromeAntiphospholipidHealth informationSurveys and questionnairesSystemic lupus erythematous

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.